Diabetes Management
Infineon accelerating the quest for an artifical pancreas with comprehensive semiconductor solutions for CGMs, SMBGs and Insulin Pumps and Pens.
The key trends in diabetes management are for reliable, smaller and less intrusive devices so people diagnostic with type I or type II conditions can go on with normal lives. Infineon provides ultra-low power processing, efficient wireless connectivity and precision anlog functionality all integrated in reliable semiconductor solutions.
Benefits :
- PSoCTM Low Power MCU
- Analog Front-end / TIA
- AIROCTM BLE and NFC Connectivity
- Authententication / IP Protection
- Data Security and Integrity
- Product Longevity
Ultra Low Power Feature does matter : Enabling longer battery lifetime
Ultra Low power consumption is a must for CGMs and Insulin Patch Pumps, to ensure the long battery lifetime, especially in deep sleep/idle modes. Infineon BLE SoC support flexible sleep modes enabling system optimization such as maintaining sensing/control activites while the radio is in sleep mode.
Robust and Reliable Connection is a must : Best user experience by no connection drops
Failed connectivity is the biggest consumer complaint with CGMs. More robust RF design and better interoperability are the key pillors. Meanwhile, longer range and low latency features are important as well. Infineon AIROC BLE SoC solutions enhance the design with leading Robust RF technology, and connection reliability which have been proven by widely deployed wireless IP in broad market.
Highly Integrated and Reference Design : High Performance BLE platform
The PSoCTM BLE Low Energy portfolio consists of highly integrated SoC devices which integrate not only processing and connectivity but also key analog blocks required to sense small signals from bio-sensors. In addition, Infineon has developed reference designs for CGMs and SMBG devices.
Product Security and Authentication : Enabling data security and product authentication
Security is a growing concern for medical devices such as CGMs and Insulin Injectors. New regulations were inacted to protect patients' data and prevent counterfeit products. Infineon SoCs includes state-of-the-art cryto engines while our Optiga Authentication technology can be deployed on medical consumable such as Insulin cartridge to eliminate counterfeiting.
